![]() ![]() ![]() The CHMP’s decision to start the rolling review is based on results from laboratory studies and clinical studies in adults. The EU applicant for this medicine is R-Pharm Germany GmbH. EMA’s human medicines committee ( CHMP) has started a rolling review of Sputnik V (Gam-COVID-Vac), a COVID-19 vaccine 1 developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |